OCEA

distress 6/10 · elevated risk

$0.00-75%today-99% from 52w high

oceanbiomedical.com7 employeesFounded 2019Providence, RIBiotechnology

Revenue

pre-revenue

Liquidity

$1M

Runway

0.4 yrs

Shares 1y

+588%

Price & events

-75.0% over 6M

CatalystRating changeDilutionFinancingdashed = today

-75.0%

-66.7%

+0.0%

-75.0%

-98.5%

-100.0%

—

-100.0%

All

Overview

Market Cap: $23.24K
Volume: 24.33K
52 Week Range: $0.00 – $0.01
Total Shares: 232.37M
Float Shares: 208.41M
Short %: 2.05%
% Held by Insiders: 10.31%
% Held by Institutions: 0.00%
RVOL: 0.71x
Beta: -0.52

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 232,365,143 · 0 offerings/1y · 0 PIPEs

2025-02-268-Kprivate_placement
2025-02-128-Kprivate_placement
2024-10-178-Kmaterial_agreement
2024-07-238-Kprivate_placement

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified